PerkinElmer, Inc. Expands Reagent Portfolio for Faster Identification of Epigenetic Drug Candidates
SAN DIEGO--(BUSINESS WIRE)--At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of four new cellular assay kits to help identify and characterize possible drug candidates targeting epigenetic enzymes related to key disease states.